Provides the latest findings in the area of medical/cancer imaging
Highlights the latest developments and future directions in the field
Presents work from leading experts and pioneers in molecular imaging
Professor Balázs Gulyás is a Professor of Translational Neuroscience at the Lee Kong Chian School of Medicine, Nanyang Technological University (NTU). Prior to this appointment, Prof Gulyás spent most of his scientific career at the world-renowned Karolinska Institutet, Stockholm, Sweden. After obtaining his MD degree at Semmelweis University, Budapest, Hungary, in 1981, he completed his PhD in neuroscience at the Catholic University of Leuven, Belgium, in 1988, followed by postdoctoral studies at the Department of Clinical Neurophysiology, Karolinska Institutet in Stockholm and at the Department of Experimental Psychology at the University of Oxford, UK. Prof Gulyás has published numerous books, written over 35 book chapters and contributed to over 180 research papers in peer-reviewed scientific journals. He is a member of Academia Europaea (The Academy of Europe), the Hungarian Academy of Sciences, and the Royal Belgian Academy of Medical Sciences.
Dr. Parasuraman Padmanabhan is the Deputy Director at the Lee Kong Chian School of Medicine at NTU. He has more than twenty-two years of research and teaching experience at leading universities, such as Cornell, Stanford University, and A*STAR. He has been working for more than a decade in the field of multimodal molecular imaging to understand the pathophysiology of several disease progressions. His research interests are in the areas of neurodegenerative disease and nanotheranostics. He is also the Series Editor for the book series SpringerBriefs in Nanotheranostics.
Dr. A. Lenin Fred has been the Principal of Mar Ephraem College of Engineering & Technology since 2010. He received his BE and ME degrees in Computer Science and Engineering from Madurai Kamarajar University, and his doctoral degree in Computer Science & Engineering, specializing in Digital Image Processing from Manonmaniam Sundaranar University, Tirunelveli, India. He has conducted extensive research in the areas of biometrics, multimodalbiometrics and medical image processing. He is the founder of the Department of Information Technology, CSI Institute of Technology, India, which he headed from 2001 to 2009.
Dr. T. R. Santhosh Kumar is a cancer research scientist working at the Rajiv Gandhi Centre for Biotechnology (RGCB) with expertise in cellular assay development, high-throughput screening, FRET probe development, and FRET imaging for in vitro and real-time in vivo imaging of tumor growth and metastasis. His work also focuses on understanding the cancer drug resistance mechanism and development of interventional approaches to bypass chemoresistance. He has developed several image-based screening tools to identify compounds that act on cancer-specific targets such as angiogenesis, invasion, tumor stem cells, hypoxia, redox, and direct caspase activators. Some of these assays are currently being used for preliminary drug screening applications in both academia and industry. Several optical imaging pre-clinical models he developed are also currently used for anticancer drug screening.
Dr. Sundramurthy Kumar completed his Ph.D. at the Anna University, Guindy Campus, Chennai, India in 1998. He is currently working at the Lee Kong Chian School of Medicine (LKC), Nanyang Technological University (NTU), Singapore as a Project Manager, Translational Neuroscience, working with the Scientific Director, Neuroscience and Mental Health to build and maintain the Human Brain Imaging platforms at the LKC, NTU. In Singapore he has pursued his postdoctoral studies at various research institutes and universities, including the Institute of Molecular Agrobiology (IMA), Institute of Molecular Cell Biology (IMCB) (A*STAR), and the School of Biological Sciences (SBS), Nanyang Technological University (NTU).
